Evidence map›Paper›PMID 32668560›Full record

ReviewCells2020

A Survey of Reported Disease-Related Mutations in the MRE11-RAD50-NBS1 Complex.

Samiur Rahman, Marella D Canny, Tanner A Buschmann, Michael P Latham

Abstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. NovelFrontiers in endocrinology · 2026
    Article
  6. Article
  7. Article
  8. Crystal structure of the folded domains of Xrs2 from Saccharomyces cerevisiae.Acta crystallographica. Section F, Structural biology communications · 2025
    Article
  9. Review
  10. Differential expression of a disease-associatedbioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Importance of Germline and Somatic Alterations in HumanInternational journal of molecular sciences · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Germline risk of clonal haematopoiesis.Nature reviews. Genetics · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samiur RahmanDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA.ORCID 0000-0002-4420-9469
Marella D CannyDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA.ORCID 0000-0002-9884-5575
Tanner A BuschmannDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA.
Michael P LathamDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409-1061, USA.ORCID 0000-0002-2209-5798

Funding

Structural Biology Studies of a Large DNA Repair ComplexR35GM128906 · NIGMS · UNIVERSITY OF MINNESOTA · PI Michael Parker Latham · 2018 to 2026
$3.1M
NIGMS NIH HHS R35 GM128906
6 · The paper itself

Abstract

The MRE11-RAD50-NBS1 (MRN) protein complex is one of the primary vehicles for repairing DNA double strand breaks and maintaining the genomic stability within the cell. The role of the MRN complex to recognize and process DNA double-strand breaks as well as signal other damage response factors is critical for maintaining proper cellular function. Mutations in any one of the components of the MRN complex that effect function or expression of the repair machinery could be detrimental to the cell and may initiate and/or propagate disease. Here, we discuss, in a structural and biochemical context, mutations in each of the three MRN components that have been associated with diseases such as ataxia telangiectasia-like disorder (ATLD), Nijmegen breakage syndrome (NBS), NBS-like disorder (NBSLD) and certain types of cancers. Overall, deepening our understanding of disease-causing mutations of the MRN complex at the structural and biochemical level is foundational to the future aim of treating diseases associated with these aberrations.

Indexed as

MutationAnimalsDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA RepairHumansMRE11 Homologue ProteinNuclear ProteinsDNA-Binding ProteinsMRE11 Homologue ProteinNuclear ProteinsATLDcancer mutationsDNA double-strand break repairMRE11-RAD50-NBS1NBS

Identifiers

PMID32668560
PMCPMC7407228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.